Clinical Trial Update: Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating soblidotin for progressive locally advanced or metastatic non-small cell lung cancer has completed enrollment/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• soblidotin (soblidotin)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED